Metabolomics study of the effect of Danggui Buxue Tang on rats with chronic fatigue syndrome.
Miao, Xiaoyao, Li, Shuo, Xiao, Bingkun et al. · Biomedical chromatography : BMC · 2022 · DOI
Quick Summary
Researchers tested whether a traditional Chinese medicine formula called Danggui Buxue Tang (DBT) could help rats with chronic fatigue syndrome caused by stress and food restriction. After 4 weeks of treatment, rats given DBT showed better energy levels, reduced fatigue markers in their blood, and improved physical performance compared to untreated rats with CFS.
Why It Matters
This study provides mechanistic insight into how a traditional remedy may alleviate CFS symptoms by identifying specific metabolic pathways and chemical imbalances involved in the disease. Understanding these pathways could help researchers develop new treatments and validate metabolomic biomarkers for ME/CFS diagnosis and monitoring in humans.
Observed Findings
Rats treated with DBT showed significantly improved endurance capacity and reduced immobility time compared to untreated CFS model rats.
Serum levels of antioxidant enzymes (superoxide dismutase and glutathione peroxidase) increased in the DBT treatment group.
Inflammatory markers (interleukin-6 and tumor necrosis factor-alpha) and oxidative stress marker (malondialdehyde) were significantly reduced in DBT-treated rats.
Fifteen significantly altered metabolites were identified in CFS rat serum, with most changes reversed following DBT treatment.
Metabolic pathway analysis implicated amino acid metabolism (glycine, serine, threonine) and related pathways as key targets of DBT action.
Inferred Conclusions
DBT alleviates CFS-like symptoms in rats through modulation of multiple metabolic pathways, particularly those involving amino acid metabolism.
Glycine, serine, and threonine metabolism appears to be most closely associated with symptom improvement by DBT.
Metabolomics is a valuable tool for understanding the mechanism of traditional Chinese medicine formulas in treating CFS.
Remaining Questions
Will DBT demonstrate similar efficacy and metabolomic changes in human patients with ME/CFS?
What This Study Does Not Prove
This rat study does not prove that DBT will be effective or safe in humans with ME/CFS. Animal models of CFS induced by acute stress and food restriction may not capture the complexity of human ME/CFS etiology. The findings show association between metabolic changes and symptom improvement but do not definitively establish causation for all identified pathways.
Tags
Symptom:Fatigue
Biomarker:CytokinesMetabolomicsBlood Biomarker
Method Flag:Weak Case DefinitionSmall SampleExploratory Only